Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

Early-life infection burden is associated with an increased risk for later moderate-to-severe infections and systemic ...

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients with ...

but the new formulation will allow patients to take greater control of their treatment. Like its predecessor, it is approved in the EU for use in patients 12 years and older with severe asthma who ...

Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations, especially those that are severe. A few hours or more may be required for systemic CS to ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, ...

An allergic reaction in babies can range from mild to life-threatening. Here’s how to tell if your child is having an ...